“Investigator- and Patient-Rated Local Tolerability in Phase 3 Trials of Topical Roflumilast in Patients With Psoriasis, Seborrheic Dermatitis, and Atopic Dermatitis”. SKIN The Journal of Cutaneous Medicine 7, no. 6 (November 13, 2023): s251. Accessed April 10, 2025. https://skin.dermsquared.com/skin/article/view/2398.